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Abstract
Introduction. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the management of pain in a variety 
of conditions. Available data clearly indicate, that the use of NSAIDs is associated with a number of adverse effects, 
especially in patients with cardiovascular disease. The aim of the study was to assess the prevalence and frequency of 
analgesic drug use in patients with coronary heart disease and knowledge about possible interactions of these drugs 
with conventional cardiac therapy.
Material and methods. The study included 183 patients with ischaemic heart disease, hospitalised in the tertiary 
cardiological centre. Data on the use of analgesics and patients’ knowledge about their safety were collected using 
self-prepared questionnaire. Information about current medication, accompanying diseases and blood-test results were 
checked in patients’ medical records.
Results. In the examined group, regular use of analgesic drugs (defined as at least three times per week) was reported 
by 29 subjects (15.8%). The most frequently used analgesics were NSAIDs and paracetamol, with their regular use re-
ported by 7.0% and 8.8% of the respondents respectively. The majority of patients using NSAIDs were not aware about 
their possible interactions with antiplatelet therapy and did not consult the use of analgesics with a physician. Only 
19.8% of patients admitted, that they received the information about analgesics from their doctor.
Conclusions. The regular use of analgesic drugs by 15.8% of patients with coronary artery disease is a significant con-
cern. Patients with coronary heart disease should be provided with detailed information and recommendations about 
safe analgesic therapy and alternatives for NSAIDs.
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Introduction
Non-opioid analgesic drugs, namely non-steroidal anti-
-inflammatory drugs (NSAIDs) and few drugs without 
significant anti-inflammatory action (paracetamol 
[acetaminophen], metamizole) are commonly used by pa-
tients in treatment of acute and chronic pain. Chronic pain 
can affect even 20.0% of the adult European population 
and its frequency increases with age and comorbidities [1]. 
NSAIDs are among the most widely used and prescribed 
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history, comorbidities, habits and medication used. The 
second part referred to the use of analgesic drugs by the 
patient in the last year and contained questions about 
the type of analgesic drug, frequency of its use, reasons 
for analgesic treatment, sources of information about 
analgesics, and questions about the communication with 
physician regarding the use of pain relieving drugs (did the 
patient consult the use of these drugs with a physician, if 
the patient received information about side effects of the 
drugs from a physician). For each type of analgesic listed, 
the patients were asked about the frequency of its use — 
the answers varied from never to more than once per day. 
Based on the reported frequency, the respondents were 
divided into two groups — regular users and non-regular/ 
/non-users. Regular analgesic drugs use was defined as 
taking them at least three times per week.
The questionnaire also analysed the patient’s aware-
ness of possible interactions of analgesics with conventio-
nal cardiac treatment and knowledge of safety of NSAIDs 
use for patients after cardiovascular events.
Information about laboratory tests and medication 
used during current hospitalisation were extracted from 
patients medical records. The study protocol was approved 
by the local ethics committee.
Statistical analysis
Statistica 12.0 software was used for data management 
and statistical analysis (StatSoft, Statistica 12.0, Tulsa, 
Oklahoma, USA). The chi-squared test was used to evaluate 
the comparisons of qualitative data, whereas t-student 
tests for quantitative data. For all the tests, the p value 
<0.05 was considered statistically significant. Quantitative 
data is expressed as mean values and standard deviations 
while qualitative variables as number and percent values. 
Results
The study group included 183 patients, 55 women (30.1%) 
and 128 men (69.9%). The mean age of the study popula-
tion was 68.7 ± 10.7 years. Seventy nine patients (43.2%) 
were hospitalised because of acute coronary syndrome 
and — 104 (56.8%) were admitted for elective coronary 
angiography. The majority of patients from the study group 
had hypertension (n = 141, 77.0%). Diabetes mellitus 
was present in 64 (35.0%) and hypercholesterolaemia 
in 109 (59.7%) subjects. There were 28 current smokers 
(15.3%) and 86 ex-smokers (47.0%) in the population 
under the study. Ninety-four patients (51.4%) included in 
the study had a history of previous myocardial infarction 
and 21 (11.4%) a history of stroke. The majority of patients 
(n = 121; 66.1%) underwent the percutaneous coronary 
intervention in the past. Diagnosis of atrial fibrillation (in the 
history or during current hospitalisation) was established 
in 75 patients (41.0%).
therapeutic agents, as they bring relief to a wide range of 
pain. Nevertheless, the efficiency of NSAIDs is limited by 
their potentially serious adverse effects. For many years, 
gastrointestinal bleeding was considered the main worry in 
relation to NSAID use. Recently, the cardiovascular safety of 
NSAIDs use has become a concern. Nowadays, it is widely 
accepted that all non-aspirin NSAIDs not only increase 
the risk of bleeding, but also increase a risk of thrombotic 
complications [2]. There are known drug-to-drug intera-
ctions of NSAIDs with some antihypertensives, diuretics 
and antithrombotic drugs. NSAIDs may compromise the 
cardioprotective effect of aspirin, competitively binding to 
COX-1 and interfering with the mechanism of antiplatelet 
activity [3].
Even short term administration of NSAIDs in patients 
after myocardial infarction was proven to increase signifi-
cantly the risk of bleeding, recurrent myocardial infarction, 
stroke and cardiovascular death [4].
Data about the cardiovascular safety of paracetamol 
and metamizole are sparse, however they are generally 
considered safe [5, 6].
Current guidelines discourage the use of NSAIDs in 
patients with coronary heart disease [7], but as those 
drugs are available over-the-counter, the real exposure of 
high-risk patients to these agents is difficult to evaluate. 
There is no data on the real-life scale of the problem of 
analgesic therapy in patients with coronary heart disease 
in the Polish population.
The purpose of this study was to analyse the preva-
lence, frequency and type of analgesic drugs used among 
patients with coronary artery disease. Additionally, we 
sought to assess the patients knowledge about possible 
interactions between analgesic drugs and conventional 
cardiac therapy.
Material and methods
The study was conducted among patients with coronary 
artery disease, hospitalised in the tertiary cardiology centre 
between October 2015 and July 2016. The main inclusion 
criterion was the diagnosis of coronary artery disease at 
the admission to the cardiological ward. The study included 
both — patients with stable angina being admitted electively 
to hospital to undergo scheduled coronary angiography and 
patients with acute coronary syndromes. The exclusion cri-
teria were inability to communicate, cognitive dysfunction 
and lack of consent.
Information about the use of analgesics were collected 
by face-to-face interviews using the self-prepared survey 
questionnaires. Questionnaires were distributed and 
collected by students from the Students’ Scientific Group 
at the Clinic. The questionnaire contained 16 closed- and 
open-ended questions. The first part comprised of the 
patient’s personal and demographic data, past medical 
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The majority of the examined patients (n = 116; 63.4%) 
were retired. Forty participants (21.9%) declared higher 
education.
In the examined group, 116 (63.4%) patients declared 
the use of analgesic drugs over the last year. Fifty patients 
(27.3%) declared the use of more than one type of anal-
gesics. The regular use of analgesics (defined as at least 
three times per week) was reported by 29 patients (15.8%) 
of the examined group.
There were no differences in age and cardiovascular 
risk factor profile between the regular analgesics users 
and the rest of the group. Regular use of analgesics was 
reported more commonly by women than men. Results are 
summarised in Table 1.
In the group of patients taking analgesics regularly, 
non-steroidal anti-inflammatory drugs and paracetamol 
were the most commonly administered medications (Tab-
le 2). Sixteen patients (8.7%) reported the regular use of 
paracetamol and 13 (7.0%) declared the regular use of 
NSAIDs. Among NSAIDs, ibuprofen was the most frequently 
used in the examined group. Regular NSAIDs users did not 
differ from analgesic drug non-users in refer to age, gender 
and burden of cardiovascular risk factors.
 The main reasons for using analgesic drugs were: 
musculoskeletal pain (n = 58), headache (n = 49) and art-
hralgia (n = 35). About half of those patients, who reported 
the use of analgesic in the last year (n = 56) declared, that 
they had received the information about analgesics from 
Table 1. Clinical characteristics of the study group with reference to the regular analgesic drug use. The data is expressed as mean valu-
es ± standard deviations (SD) for continuous variables or number and percent for categorical variables
Regular analgesic drug user 
N = 29
Non-users/non-regular analgesic drug user 
N = 154
p*
Age (years) 70.4 ± 11.5 68.4 ± 10.6 0.37
Female n (%) 13 (44.8%) 42 (27.3%) 0.05
Hypertension n (%) 23 (79.3%) 118 (76.6%) 0.48
Diabetes mellitus n (%) 13 (44.8%) 51 (33.1%) 0.15
Hyperlipidaemia n (%) 13 (44.8%) 61 (39.6%) 0.37
Smoking n (%) 3 (10.3%) 25 (16.2%) 0.31
Urgent admission to hospital n (%) 12 (41.3%) 67 (43.5%) 0.61
Previous myocardial infarction n (%) 13 (44.8%) 81 (52.6%) 0.28
Previous stroke n (%) 6 (20.7%) 15 (9.7%) 0.08
BMI (kg/m2) 28.5 ± 6.3 28.3 ± 5.6 0.91
Serum creatinine (µmol/l) 98.3 ± 38.2 98.4 ± 61.2 0.99
Serum glucose (mmol/l) 7.3 ± 3.1 6.4 ± 2.3 0.09
Total cholesterol (mmol/l) 4.4 ± 1.3 4.2 ± 1.2 0.40
LDL-cholesterol (mmol/l) 2.4 ± 1.1 2.3 ± 1.1 0.67
HDL-cholesterol (mmol/l) 1.3 ± 0.4 1.2 ± 0.4 0.27
Triglicerides (mmol/l) 1.4 ± 0.6 1.4 ± 0.7 0.67
*p value calculated with t-Student test for independent variables (continuous variables) and Chi-square (categorical variables); BMI — body mass index
Table 2. Analgesic drugs use reported by patients with ischae-
mic heart disease (irrespective of the frequency of use). Some 
patients used more than one drug and therefore the number of 
patients and percentages do not add up to 183 and 100 respec-
tively
Drug Number of patients, n (%)
NSAIDs
ibuprofen
aspirin (acetylsalicylic acid)
ketoprofen
diclofenac
nimesulid
meloxicam
naproxen
107 (58.5%)
39 (21.3%)
27 (14.7%)
19 (10.3%)
15 (8.2%)
4 (2.2%)
3 (1.6%)
1 (0.5%)
paracetamol 66 (36.0%)
metamizole 9 (4.9%)
tramadol 6 (3.3%)
family, acquaintances and advertising on TV. Only 44.0% 
(n = 51) of patients taking analgesic drugs consulted it with 
their physicians. The majority of subjects using analgesics 
(n = 93; 80.2%) did not receive any information about drug-
-to-drug interactions and side effects of these medications. 
Only 38 patients (20.8%) were able to answer correctly 
286
Folia Cardiologica 2018, vol. 13, no. 4
www.journals.viamedica.pl/folia_cardiologica
for question about possible interactions of analgesics 
with antiplatelet drugs. Twelve patients (13.9%) believed 
that using analgesics has no influence on antiplatelet 
therapy. Most analgesic drug users did not know if these 
drugs can interfere with antiplatelet medication (n = 133; 
72.7%). Similarly, the patients were not aware of possible 
interactions of analgesics with antihypertensive therapy 
(answer “yes” was given only by 39 respondents and “do 
not know” by 116 patients, 28 participants reported that 
there are no interactions between analgesics and antihy-
pertensive medication). Seventy-five respondents (41.0%) 
reported concerns about safety of analgesics in patients 
after myocardial infarction, while 25 (13.7%) believed that 
analgesic use after myocardial infarction is safe.
Discussion
The study demonstrated that the use of analgesic drugs by 
patients with coronary artery disease is frequent, reported 
by 63.4% (n = 116) of participants. In our study almost 
16% of participants declared the regular use of analgesic 
drugs, defined as at least three times a week. As our study 
was conducted in selected population of high-risk patients 
with established coronary heart disease, it makes it difficult 
to compare the results directly with those coming from 
general population.
Nonetheless, the wide use of analgesics in the past 
year was also documented in previous large studies con-
ducted in general population, investigating the same time 
period. Wilcox et al. showed, that among 9083 general 
population respondents, 83.0% of individuals reported 
over-the-counter analgesics use in the past year, and 
37.0% of those, reported using them daily or several times 
a week [8]. In the Dutch study examining the frequency 
of over-the-counter NSAIDs use in general population, the 
high-risk sample was separately analysed, revealing that 
regular use of NSAIDs was reported by 13.0% of high-risk 
participants [9]. The prospective study undertaken in 
myocardial infarction survivors, proved that at least one 
prescription claim for NSAIDs treatment after discharge 
was identified for 33.8% of patients [4]. This Danish study 
documented, that even short administration of NSAIDs 
resulted in significant increase of both bleeding risk and 
risk of thrombotic events . There was no safe therapeutic 
window for NSAIDs co-administration, because even short-
-term (0–3 days) treatment was related with the increa-
sed risk. Similar results come from recently published 
meta-analysis, based on the data of 446 763 individuals, 
showing that NSAIDs use is associated with increased risk 
of myocardial infarction [10].
 In our study, regular NSAIDs use was reported by 
7.0% of participants, but taking into account the absolute 
number of patients with coronary heart disease it remains 
a significant concern. In Poland in 2014 the total number 
of percutaneous coronary procedures performed was 
126 241 [11], which in the context of our results (7.0% re-
gular NSAIDs users) may translate into over 8800 subjects 
yearly exposed to potentially harmful analgesic therapy.
 Precise summary information on cardiovascular risk 
with NSAIDs has been available since 2006 and current gu-
idelines of the European Society of Cardiology discourage 
the use of non-aspirin NSAIDs in patients with established 
or at high risk of cardiovascular disease [7]. Pain treatment 
should begin with paracetamol and optimisation of treat-
ment of underlying disease, then weak opioids use may 
be considered. If initial therapy is insufficient, it is reaso-
nable to use nonselective NSAIDs such as naproxen [12]. 
Evidence suggests that there are significant differences 
between commonly used members of the NSAIDs class 
[13]. In our study, the most popular NSAIDs were ibuprofen, 
ketoprofen and diclofenac. Naproxen, which still appears 
to have the least harmful cardiovascular risk profile, also 
in patients with myocardial infarction and heart failure, 
was used only by one subject.
 Nevertheless, even when analgesic therapy was 
prescribed by a doctor, the patients did not receive ade-
quate information and NSAIDs were perceived as safe 
drugs without significant interaction with co-administered 
cardiovascular medication. Low awareness about the 
adverse effects of NSAIDs was also documented in other 
studies [14, 15].
On the other hand, in the examined population, the 
regular use of paracetamol was reported with equal fre-
quency to the regular use of NSAIDs. The cross-sectional 
character of our study does not allow for interpretation 
of the time-trends and proportions between NSAIDs and 
paracetamol use in the last decade, but it cannot be 
excluded, that although general awareness of analgesic 
safety is unsatisfactory, paracetamol was chosen as a safer 
alternative for pain therapy.
Paracetamol has been considered as safe and relati-
vely effective for some forms of minor pain. The influence 
of paracetamol on cardiovascular events was examined 
only in a few studies, some of them linked paracetamol use 
with blood pressure elevation, hypertension development 
and myocardial infarction incidence [6]. Recent retrospec-
tive analysis confirmed the cardiovascular safety of para-
cetamol in 10878 exposed subjects followed by ten years 
[16], supporting the choice of paracetamol therapy for 
pain in patients presenting with cardiovascular risk factors.
 In our study, the female gender was associated with 
regular analgesic drug use. Similar observations were repor-
ted by others. In the Norwegian population, the use of over-
-the-counter analgesics was related to the female gender, 
physical inactivity and chronic pain [17]. Data from NHANES 
survey also indicated, that women were more likely to use 
NSAIDs regularly [18]. Higher prevalence of analgesics use 
in women compared to men is probably related to gender 
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questionnaires force the respondent to answer questions 
that he or she may be ignorant or have different under-
standing based on personal perception. Face-to-face 
survey and direct administration of the questionnaire in 
our study should improve the quality of data collected and 
minimise the errors related to difficulties in understanding 
the complex questions.
The study sample is relatively small, but its characte-
ristics reflects the typical profile of patients with coronary 
heart disease. Our study, conducted among subjects 
hospitalised to undergo coronary artery intervention, illu-
strates real-life prevalence of regular analgesics drug use. 
Although we were not able to clearly define the coexisting 
diseases requiring analgesics, we have proven, that pain 
treatment remains problematic and needs appropriate 
caution and attention.
Conclusions
The regular use of analgesic drugs by 15.8% of patients with 
coronary artery disease is a significant concern. Women are 
more likely than men to be regular analgesic drugs users. 
Patients with coronary heart disease should be provided 
with detailed information and recommendations about safe 
analgesic therapy and alternatives for NSAIDs.
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differences in pain perception, efficacy of pain medication 
and prevalence of chronic non-malignant pain [19].
 We were not able to identify other factors related with 
regular analgesic drug use. The group of regular analgesic 
drug-users did not differ with regard to age and comorbi-
dities from the rest of the interviewed patients. Previous, 
larger population-based studies identified poor self-rated 
health, increasing age, obesity and smoking as factors re-
lated with continuous regular analgesic use [20]. Relatively 
narrow age range and limited number of participants, as 
well as homogeneous population of high cardiovascular 
risk patients under the study may be responsible for this 
discrepancy in the obtained results.
Identification of regular analgesic drug users characte-
ristics is important, as understanding who is likely to use 
NSAIDs enables more targeted messaging.
Based on our results, it is clear that there is a need to 
improve patients knowledge about potential interactions 
of analgesic drugs with standard antianginal therapy.
Thus, we suggest that in patients with established 
coronary heart disease and especially those undergoing 
interventional therapies requiring subsequent dual antipla-
telet therapy or combined antiplatelet and anticoagulant 
therapy, detailed history regarding the use of analgesic 
drugs should be taken and clear instructions about safe 
pain therapy should be provided. 
There are several limitations of our study. The stu-
dy was based on questionnaires, and the structure of 
the method itself may bias the results. Fixed-choice 
Streszczenie
Wstęp. Niesteroidowe leki przeciwzapalne (NLPZ) są powszechnie używane do uśmierzania bólu w przebiegu różnorod-
nych schorzeń. Dostępne dane jasno wskazują, że stosowanie NLPZ jest związane ze znaczną liczbą efektów ubocznych, 
zwłaszcza wśród pacjentów z chorobą sercowo-naczyniową. Celem pracy było określenie częstości stosowania leków 
przeciwbólowych wśród pacjentów z chorobą niedokrwienną serca oraz wiedzy pacjentów na temat potencjalnych inter-
akcji tych leków ze standardowym leczeniem kardiologicznym.
Materiał i metody. Badanie przeprowadzono wśród 183 pacjentów z chorobą niedokrwienną serca hospitalizowanych 
w referencyjnym ośrodku kardiologicznym. Dane na temat stosowania leków przeciwbólowych oraz wiedzy pacjentów 
o ich bezpieczeństwie były pozyskiwane z użyciem kwestionariusza. Informacje na temat przyjmowanych leków, współ-
istniejących chorób oraz badań laboratoryjnych zostały uzyskane z historii chorób pacjentów.
Wyniki. Regularne stosowanie leków przeciwbólowych (co najmniej trzykrotne w ciągu tygodnia) zadeklarowało 29 pa-
cjentów (15,8%). Najczęściej stosowanymi lekami przeciwbólowymi były NLPZ oraz paracetamol, których regularne sto-
sowanie podało 7% i 8,8% osób. Większość pacjentów stosujących NLPZ nie było świadomych potencjalnych interakcji 
tych leków z terapią przeciwpłytkową i nie konsultowało stosowania leków przeciwbólowych z lekarzem. Zaledwie 19,8% 
pacjentów przyznało, że otrzymało informację na temat leków przeciwbólowych od lekarza.
Wnioski. Regularne stosowanie leków przeciwbólowych przez 15,8% pacjentów z chorobą wieńcową serca stanowi 
istotny problem. Pacjenci z chorobą wieńcową serca powinni otrzymywać dokładne informacje oraz zalecenia na temat 
bezpiecznej terapii przeciwbólowej oraz alternatywy dla NLPZ.
Słowa kluczowe: choroba wieńcowa serca, leki przeciwbólowe, NLPZ, ryzyko sercowo-naczyniowe
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288
Folia Cardiologica 2018, vol. 13, no. 4
www.journals.viamedica.pl/folia_cardiologica
References
1. van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its 
clinical relevance. Br J Anaesth. 2013; 111(1): 13–18, doi: 10.1093/ 
/bja/aet123, indexed in Pubmed: 23794640.
2. Baigent C, Bhala N, Emberson J, et al. Vascular and upper gastrointe-
stinal effects of non-steroidal anti-inflammatory drugs: meta-analyses 
of individual participant data from randomised trials. The Lancet. 
2013; 382(9894): 769–779, doi: 10.1016/s0140-6736(13)60900-9.
3. Nalamachu S, Pergolizzi J, Raffa R, et al. Drug-drug interaction 
between NSAIDS and low-dose aspirin: a focus on cardiovascular 
and GI toxicity. Expert Opin Drug Saf. 2014; 13(7): 903–917, doi: 
10.1517/14740338.2014.924924.
4. Schjerning Olsen AM, Gislason GH, McGettigan P, et al. Association of 
NSAID use with risk of bleeding and cardiovascular events in patients 
receiving antithrombotic therapy after myocardial infarction. JAMA. 
2015; 313(8): 805–814, doi: 10.1001/jama.2015.0809, indexed in 
Pubmed: 25710657.
5. Andrade S, Bartels DB, Lange R, et al. Safety of metamizole: a syste-
matic review of the literature. J Clin Pharm Ther. 2016; 41(5): 459– 
–477, doi: 10.1111/jcpt.12422, indexed in Pubmed: 27422768.
6. Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory 
drugs, acetaminophen, and the risk of cardiovascular events. Circu-
lation. 2006; 113(12): 1578–1587, doi: 10.1161/CIRCULATIONA-
HA.105.595793, indexed in Pubmed: 16534006.
7. Roffi M, Patrono C, Collet JP, et al. Authors, ESC Scientific Document 
Group. 2015 ESC Guidelines for the management of acute corona-
ry syndromes in patients presenting without persistent ST-segment 
elevation: Task Force for the Management of Acute Coronary Syndro-
mes in Patients Presenting without Persistent ST-Segment Elevation 
of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37(3): 
267–315, doi: 10.1093/eurheartj/ehv320, indexed in Pubmed: 
26320110.
8. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public 
perception of over-the-counter pain relievers: focus on nonsteroidal 
antiinflammatory drugs. J Rheumatol. 2005; 32(11): 2218–2224, 
indexed in Pubmed: 16265706.
9. Koffeman AR, Valkhoff VE, Celik S, et al. High-risk use of over-the-
-counter non-steroidal anti-inflammatory drugs: a population-based 
cross-sectional study. Br J Gen Pract. 2014; 64(621): e191–e198, doi: 
10.3399/bjgp14X677815, indexed in Pubmed: 24686883.
10. Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction 
with NSAIDs in real world use: bayesian meta-analysis of individual 
patient data. BMJ. 2017; 357: j1909, indexed in Pubmed: 28487435.
11. Ochała A, Siudak Z, Legutko J, et al. Percutaneous interventions in 
cardiology in Poland in the year 2014. Summary report of the Asso-
ciation of Cardiovascular Interventions of the Polish Cardiac Society 
AISN PTK. Post Kardiol Interw. 2015; 11(3): 177–181, doi: 10.5114/
pwki.2015.54009, indexed in Pubmed: 26677356.
12. Schmidt M, Lamberts M, Olsen AM, et al. Cardiovascular safety of 
non-aspirin non-steroidal anti-inflammatory drugs: review and posi-
tion paper by the working group for Cardiovascular Pharmacotherapy 
of the European Society of Cardiology. Eur Heart J. 2016; 37(13): 
1015–1023, doi: 10.1093/eurheartj/ehv505.
13. Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-
-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011; 
342(jan11 1): c7086–c7086, doi: 10.1136/bmj.c7086.
14. Karakitsiou M, Varga Z, Kriska M, et al. Risk perception of NSAIDs in 
hospitalized patients in Greece. Bratisl Lek Listy. 2017; 118(7): 427– 
–430, doi: 10.4149/BLL_2017_083, indexed in Pubmed: 28766354.
15. Varga Z, Kriška M, Kristová V, et al. Analysis of non-steroidal anti-
-inflammatory drug use in hospitalized patients and perception of 
their risk. Interdiscip Toxicol. 2013; 6(3): 141–144, doi: 10.2478/ 
/intox-2013-0022, indexed in Pubmed: 24678251.
16. Fulton RL, Walters MR, Morton R, et al. Acetaminophen use and risk 
of myocardial infarction and stroke in a hypertensive cohort. Hyper-
tension. 2015; 65(5): 1008–1014, doi: 10.1161/HYPERTENSIONA-
HA.114.04945, indexed in Pubmed: 25801870.
17. Dale O, Borchgrevink PC, Fredheim OM, et al. Prevalence of use of 
non-prescription analgesics in the Norwegian HUNT3 population: Im-
pact of gender, age, exercise and prescription of opioids. BMC Public 
Health. 2015; 15: 461, doi: 10.1186/s12889-015-1774-6, indexed 
in Pubmed: 25934132.
18. Davis JS, Lee HY, Kim J, et al. Use of non-steroidal anti-inflammatory 
drugs in US adults: changes over time and by demographic. Open 
Heart. 2017; 4(1): e000550, doi: 10.1136/openhrt-2016-000550, 
indexed in Pubmed: 28674622.
19. Khan F, Ahmed A, Chawla T, et al. Effect of gender on pain perception 
and analgesic consumption in laparoscopic cholecystectomy: An ob-
servational study. J Anaesthesiol Clin Pharmacol. 2013; 29(3): 337, 
doi: 10.4103/0970-9185.117095.
20. Hargreave M, Andersen TV, Nielsen A, et al. Factors associated with 
a continuous regular analgesic use - a population-based study of more 
than 45,000 Danish women and men 18-45 years of age. Pharma-
coepidemiol Drug Saf. 2010; 19(1): 65–74, doi: 10.1002/pds.1864, 
indexed in Pubmed: 19757417.
